Paul Song

Chief Scientific Officer Genequantum Healthcare

Seminars

Tuesday 4th November 2025
Next-Generation Bioconjugate Therapeutics: Driving Innovation With Revolutionary Conjugation Technologies
11:30 am
  • Overviewing GeneQuantum’s holistic conjugation and manufacturing platforms: iLDC and iGDC
  • Introducing the world’s first rapid ADC screening system: iScreener
  • Empowering best-in-class and first-in-class XDC therapeutic development through GeneQuantum’s leading technology platform
Paul Song - 16th World ADC San Diego